Total Payments
$8,215
2024 Payments
$1,072
Companies
38
Transactions
600
Medicare Patients
7,187
Medicare Billing
$620,004
Payment Breakdown by Category
Food & Beverage$8,105 (98.7%)
Education$110.34 (1.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,105 | 585 | 98.7% |
| Education | $110.34 | 15 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,390 | 102 | $0 (2024) |
| Novo Nordisk Inc | $1,332 | 102 | $0 (2024) |
| ABBVIE INC. | $852.64 | 46 | $0 (2024) |
| PFIZER INC. | $665.40 | 75 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $534.58 | 33 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $432.39 | 37 | $0 (2024) |
| Lilly USA, LLC | $409.46 | 30 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $334.48 | 23 | $0 (2024) |
| Merck Sharp & Dohme LLC | $304.41 | 19 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $201.75 | 16 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,072 | 62 | Novo Nordisk Inc ($223.22) |
| 2023 | $1,050 | 62 | Novo Nordisk Inc ($365.97) |
| 2022 | $1,064 | 64 | Novo Nordisk Inc ($212.27) |
| 2021 | $567.53 | 29 | AbbVie Inc. ($329.90) |
| 2020 | $544.64 | 34 | GlaxoSmithKline, LLC. ($96.93) |
| 2019 | $1,390 | 115 | GlaxoSmithKline, LLC. ($237.69) |
| 2018 | $1,109 | 96 | GlaxoSmithKline, LLC. ($240.52) |
| 2017 | $1,418 | 138 | PFIZER INC. ($157.78) |
All Payment Transactions
600 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Diabetes Care | ||||||
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: DIABETES | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.36 | General |
| Category: Cardiovascular | ||||||
| 11/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Cardio-renal | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: VACCINE | ||||||
| 10/24/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: RESPIRATORY | ||||||
| 10/09/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Endocrinology | ||||||
| 10/09/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: VACCINES | ||||||
| 10/01/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $1.90 | General |
| Category: VACCINES | ||||||
| 09/18/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.59 | General |
| 09/17/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: Diabetes | ||||||
| 09/03/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: RESPIRATORY | ||||||
| 08/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $10.90 | General |
| Category: Obesity | ||||||
| 08/06/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: VACCINE | ||||||
| 07/24/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: VACCINES | ||||||
| 07/24/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $1.54 | General |
| Category: VACCINES | ||||||
| 07/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,956 | 2,909 | $256,265 | $176,658 |
| 2022 | 29 | 2,031 | 3,009 | $274,619 | $171,172 |
| 2021 | 23 | 1,654 | 2,603 | $214,341 | $145,626 |
| 2020 | 22 | 1,546 | 2,521 | $206,365 | $126,547 |
Total Patients
7,187
Total Services
11,042
Medicare Billing
$620,004
Procedure Codes
100
All Medicare Procedures & Services
100 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 257 | 529 | $68,770 | $43,234 | 62.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 274 | 599 | $55,108 | $32,961 | 59.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 192 | 192 | $27,456 | $23,399 | 85.2% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 117 | 117 | $17,990 | $14,420 | 80.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 186 | 194 | $16,875 | $13,763 | 81.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 76 | 333 | $21,312 | $13,566 | 63.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 187 | 195 | $6,240 | $5,684 | 91.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 20 | 20 | $6,650 | $5,370 | 80.8% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 130 | 130 | $5,893 | $4,987 | 84.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 23 | 23 | $4,255 | $3,471 | 81.6% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 80 | 83 | $3,735 | $3,142 | 84.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 12 | 12 | $3,660 | $2,457 | 67.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $3,743 | $1,900 | 50.8% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 13 | 13 | $2,275 | $1,859 | 81.7% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 32 | 35 | $1,575 | $1,379 | 87.5% |
| 0134A | Adm sarscv2 bvl 50mcg/.5ml a | Office | 2023 | 27 | 28 | $1,260 | $1,060 | 84.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 61 | 98 | $1,470 | $924.83 | 62.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 13 | 16 | $1,520 | $634.55 | 41.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 18 | 18 | $576.00 | $530.10 | 92.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 49 | 52 | $1,872 | $498.38 | 26.6% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 20 | 22 | $1,386 | $460.31 | 33.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 11 | 21 | $525.00 | $324.40 | 61.8% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 61 | 61 | $610.00 | $244.53 | 40.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 46 | 60 | $480.00 | $204.60 | 42.6% |
| 90471 | Administration of vaccine | Office | 2023 | 19 | 23 | $805.00 | $174.53 | 21.7% |
About Dr. Melissa Baylor, DO
Dr. Melissa Baylor, DO is a Family Medicine healthcare provider based in Dover, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205851219.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Melissa Baylor, DO has received a total of $8,215 in payments from pharmaceutical and medical device companies, with $1,072 received in 2024. These payments were reported across 600 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($8,105).
As a Medicare-enrolled provider, Baylor has provided services to 7,187 Medicare beneficiaries, totaling 11,042 services with total Medicare billing of $620,004. Data is available for 4 years (2020–2023), covering 100 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Dover, PA
- Active Since 07/12/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1205851219
Products in Payments
- TRELEGY ELLIPTA (Drug) $532.82
- XARELTO (Drug) $478.23
- Ozempic (Drug) $444.44
- Rybelsus (Drug) $382.09
- SHINGRIX (Biological) $283.05
- JARDIANCE (Drug) $252.85
- CHANTIX (Drug) $224.67
- VRAYLAR (Drug) $200.13
- ELIQUIS (Drug) $193.65
- BREO (Drug) $180.30
- UBRELVY (Drug) $168.49
- SYNTHROID (Drug) $166.22
- TRULICITY (Drug) $161.82
- FARXIGA (Drug) $148.45
- ANORO (Drug) $145.81
- Saxenda (Drug) $144.65
- Trintellix (Drug) $144.42
- ENTRESTO (Drug) $132.05
- Wegovy (Drug) $126.19
- LINZESS (Drug) $123.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Dover
Gary Czulada, Do, DO
Family Medicine — Payments: $17,476
Family Medicine $17,476
Dr. Nadiene Haynes, Md, MD
Family Medicine — Payments: $10,550
Family Medicine $10,550
Lawrence Lewandowski, Md, MD
Family Medicine — Payments: $7,945
Family Medicine $7,945
Dr. Thuya Aye, Md, MD
Family Medicine — Payments: $7,414
Family Medicine $7,414
Robert Jones, Md, MD
Family Medicine — Payments: $4,943
Family Medicine $4,943
Dr. Paul Ford, M.d, M.D
Family Medicine — Payments: $3,995
Family Medicine $3,995